Author
Listed:
- Miriam Fanjul-Fernández
(Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
- Víctor Quesada
(Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
- Rubén Cabanillas
(Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA))
- Juan Cadiñanos
(Instituto de Medicina Oncológica y Molecular de Asturias (IMOMA))
- Tania Fontanil
(Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
- Álvaro Obaya
(Biología Funcional, Facultad de Medicina, Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
- Andrew J. Ramsay
(Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
- José L. Llorente
(Servicio de Otorrinolaringología, Instituto Universitario de Oncología (IUOPA), Hospital Universitario Central de Asturias)
- Aurora Astudillo
(Anatomía Patológica, Instituto Universitario de Oncología (IUOPA), Hospital Universitario Central de Asturias)
- Santiago Cal
(Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
- Carlos López-Otín
(Instituto Universitario de Oncología (IUOPA), Universidad de Oviedo)
Abstract
Laryngeal squamous cell carcinoma is a frequent and significant cause of morbidity and mortality. Here we explore the biological basis of this aggressive tumour, and identify two cell–cell adhesion genes as recurrently mutated in this malignancy. We first perform exome sequencing of four laryngeal carcinomas and their matched normal tissues. Among the 569 genes found to present somatic mutations, and based on their recurrence or functional relevance in cancer, we select 40 for further validation in 86 additional laryngeal carcinomas. We detect frequent mutations (14 of 90, 15%) in CTNNA2 and CTNNA3-encoding α-catenins. Functional studies reveal an increase in the migration and invasive ability of head and neck squamous cell carcinoma cells producing mutated forms of CTNNA2 and CTNNA3 or in cells where both α-catenins are silenced. Analysis of the clinical relevance of these mutations demonstrates that they are associated with poor prognosis. We conclude that CTNNA2 and CTNNA3 are tumour suppressor genes frequently mutated in laryngeal carcinomas.
Suggested Citation
Miriam Fanjul-Fernández & Víctor Quesada & Rubén Cabanillas & Juan Cadiñanos & Tania Fontanil & Álvaro Obaya & Andrew J. Ramsay & José L. Llorente & Aurora Astudillo & Santiago Cal & Carlos López-Otín, 2013.
"Cell–cell adhesion genes CTNNA2 and CTNNA3 are tumour suppressors frequently mutated in laryngeal carcinomas,"
Nature Communications, Nature, vol. 4(1), pages 1-9, December.
Handle:
RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3531
DOI: 10.1038/ncomms3531
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:4:y:2013:i:1:d:10.1038_ncomms3531. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.